Our in vitro and in vivo studies also imply that OTSSP167 significantly suppresses mammosphere formation of breast cancer cells as well as the growth of human cancer-derived xenografts in mice, implying that OTSSP167 has great potential to apply as a novel therapeutics for cancer in a MELK-dependent manner. The gene discussed is MELK; the disease is breast cancer.